Imfinzi Approved as First Perioperative Immunotherapy for Bladder Cancer

Read more

Lexicon Pharmaceuticals Signs Exclusive License Agreement with Novo Nordisk for LX9851

Read more

Ionis Expands Partnership with Sobi for Olezarsen Commercialization Outside the U.S.

Read more

Soleno Therapeutics Wins FDA Approval for VYKAT XR to Treat Hyperphagia in Prader-Willi Syndrome

Read more

Merck’s Subcutaneous Pembrolizumab Shows Noninferior Pharmacokinetics to IV KEYTRUDA

Read more

European Commission Approves Merck’s CAPVAXIVE for Pneumococcal Disease in Adults

Read more

Character Biosciences Raises $93M Series B for Eye Disease Precision Medicine

Read more

FDA Grants Fast Track to Chlamydia Vaccine Candidate

Read more

Novo Holdings Joins €23M Series A for Tribune Therapeutics to Advance Anti-Fibrotic Therapies

Read more

MSD Secures Exclusive License for HRS-5346 from Jiangsu Hengrui

Read more